Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.
about
In-stent stenosis: pathology and implications for the development of drug eluting stentsThe representative porcine model for human cardiovascular diseaseNeointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcineRapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cellsOral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels.The road ahead: working towards effective clinical translation of myocardial gene therapies.Preclinical study of a biodegradable polymer-based stent with abluminal sirolimus release.Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.Effects of combined therapy with ezetimibe plus simvastatin after drug-eluting stent implantation in a porcine coronary restenosis model.The effects of rapamycin on lens epithelial cell proliferation, migration, and matrix formation: an in vitro study.Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation.Central role of RAGE-dependent neointimal expansion in arterial restenosis.Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent modelImpact of transport and drug properties on the local pharmacology of drug-eluting stents.Therapeutic potential of active stent coating.Targeting the cell cycle machinery for the treatment of cardiovascular disease.A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary arteriesEarly experiences and clinical implications of drug-eluting stents: part 1.Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery.Rapamycin impairs endothelial cell function in human internal thoracic arteries.Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis.Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.Sirolimus-eluting coronary stents: a review.Gene therapy for the extension of vein graft patency: a review.Association between in vivo bone formation and ex vivo migratory capacity of human bone marrow stromal cellsComparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.The future of drug eluting stents.Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation.Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model.Update on drug-eluting stents for prevention of restenosis.In vivo Evaluation of Cenderitide-Eluting Stent (CES) II.Coronary artery restenosis: vascular biology and emerging therapeutic strategies.A patient with repeated catastrophic multi-vessel coronary spasm after zotarolimus-eluting stent implantation.Anti-inflammatory effects of arsenic trioxide eluting stents in a porcine coronary model.p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in mice.Gene and cell therapy for chronic ischaemic heart disease.Restenosis after percutaneous angioplasty: the role of vascular inflammation.Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells.Pathology of atherosclerosis and stentingTechniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral Artery
P2860
Q24674571-E3D177D4-A5F4-45AC-8132-AABA4DBC5C6CQ27692622-70589ED5-D6C8-4402-8082-FA9028DA89F1Q28212482-95586EED-C72C-4B58-96C0-A6E01CE4FD69Q28482627-85AF8884-38D3-4D9A-B270-0A06C4B32BCBQ30482901-9630228D-EEE9-4D40-80B8-275863A148FEQ33705144-CE670C17-58B9-40A8-BF5D-5BBC2AFF448BQ33733393-ADCC9ECE-945C-4054-87F1-142F6E141198Q33776274-92BCF1FA-DDC0-4A51-BB16-E5F0DB7E3F22Q33807236-16C140D5-9C49-496D-87A6-D2B49EE79965Q34081387-D6DCA5AF-E45E-4F3C-937C-FBC2674CC2A8Q34109253-00FC9153-B755-47C0-A13B-7FBE88A9D495Q34890522-C713350A-7B5C-4FB2-BC02-A3E8D2305DFFQ35013930-C66A3636-3BDE-4F2B-87EC-0E7ABB35B365Q35080387-BA879E34-AAEE-4C3D-A077-E0CC3DA53E54Q35117070-33B08847-53E1-4F12-92C2-2E11FFA31106Q35164884-12ED8D94-E594-442F-8883-1CE5C0C0E32CQ35572141-595A983F-9017-4C99-9432-78D7F3EDD0CAQ35651217-26EBBF99-8821-45F3-A8DE-3EE47E65C47EQ35784102-2D13E0BF-95C4-43E6-B798-56378F550CF0Q35852325-1835A310-F634-4153-95A3-0D240198FAA4Q35925484-DC40E56A-BB04-4D32-8EA2-78695F6B0136Q35945466-CCB29F53-673C-4007-9719-967BBC1D30CAQ36013104-6E2900C4-2FE1-4BE5-A36E-EF59CD1FDC35Q36032833-1FC0D37F-8D45-442B-8660-197ECF8A0DE2Q36141009-C9A8BE9C-47D9-4DE0-A8A2-25A09039DF07Q36146253-D2A7D6B4-D214-4C04-AD42-B0ECF90FC695Q36282715-BF608FBD-615D-42D1-8FE9-644EA013A105Q36283698-C16D7BCF-287E-41D0-BFC7-D81F411F5061Q36374512-B5E81C5B-2803-42F6-96CF-CC05B4E66B75Q36375853-CD2E8710-240F-4057-9E4E-F965FC7B70CCQ36470750-91FAF802-786C-4491-BC37-3F229D7C3504Q36569798-91E9C43E-2068-44BE-9039-54963E973D5FQ36601920-456C224E-478A-4753-8F76-B7D12DF3798EQ36635049-803D2A70-8EAC-4B72-8900-FB8733F51463Q36638961-26285D7F-E49C-466F-92BF-DCF8246F4D3CQ36675432-B030D8DE-8D16-44D7-873D-D9FF30CC8606Q36743813-09842E69-57F6-438C-832C-8589EA5793A9Q36861726-B9EEF719-8A41-4B28-8290-CF7717271799Q36934746-D7E692E6-B28A-4A87-9B46-0CC7717639F4Q37102287-D531E78E-CA44-48A2-84A8-6AC40F7ED118
P2860
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Stent-based delivery of siroli ...... n in a porcine coronary model.
@en
Stent-based delivery of siroli ...... n in a porcine coronary model.
@nl
type
label
Stent-based delivery of siroli ...... n in a porcine coronary model.
@en
Stent-based delivery of siroli ...... n in a porcine coronary model.
@nl
prefLabel
Stent-based delivery of siroli ...... n in a porcine coronary model.
@en
Stent-based delivery of siroli ...... n in a porcine coronary model.
@nl
P2093
P356
P1433
P1476
Stent-based delivery of siroli ...... n in a porcine coronary model.
@en
P2093
Falotico R
Klugherz BD
Papandreou G
P304
P356
10.1161/HC3601.093987
P407
P577
2001-09-01T00:00:00Z